EUVIMEDEUVIMED entdecken
Crossref

Chondroitin sulfate-based microneedles for transdermal delivery of stem cell-derived extracellular vesicles to treat rheumatoid arthritis

Van Dat Bui, Jueun Jeon, Van Hieu Duong, Sol Shin, Jungmi Lee, Farrokhroo Ghahari, Chan Ho Kim, Yu Jin Jo, Won-Kyo Jung, Wooram Um, Jae Hyung Park

Journal of Controlled Release · 2024-11 · 375 · 105-115

DOI: 10.1016/j.jconrel.2024.08.050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-11. Verfasst von Van Dat Bui und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, College of Engineering, Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea. Hauptthemen laut MEDLINE: Chondroitin Sulfates, Extracellular Vesicles, Arthritis, Rheumatoid, Needles. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Ministry of Health and Welfare, Ministry of Science, ICT and Future Planning, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For the non-invasive treatment of rheumatoid arthritis (RA), a chondroitin sulfate C (CSC)-based dissolving microneedles (cMN) was prepared to deliver human adipose stem cell-derived extracellular vesicles (hASC-EV) into inflamed joints. Owing to their anti-inflammatory function, the hASC-EV-bearing cMN (EV@cMN) significantly suppressed activated fibroblast-like synoviocytes (aFLS) and M1 macrophages (M1), which are responsible for the progression of RA. In addition, EV@cMN facilitated the chondrogenic differentiation of bone marrow-derived stem cells. In mice with collagen-induced arthritis, EV@cMN efficiently delivered both hASC-EV and CSC to inflamed joints. Interestingly, pro-inflammatory cytokines in the inflamed joints were remarkably downregulated by the synergistic effect of CSC and hASC-EV. Consequently, as judged from the overall clinical score and joint swelling, EV@cMN showed an outstanding therapeutic effect, even comparable to the wild-type mice, without significant adverse effects. Overall, EV@cMN might have therapeutic potential for RA by efficiently delivering CSC and hASC-EV into the inflamed joints in a non-invasive manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chondroitin SulfatesExtracellular VesiclesArthritis, RheumatoidNeedlesStem CellsAdministration, CutaneousAnimalsHumansArthritis, ExperimentalMaleMiceSynoviocytesMice, Inbred C57BLAdipose TissueCytokinesDrug Delivery SystemsCells, Cultured

Stichwörter der Autor:innen

Chondroitin sulfateDissolving microneedlesExtracellular vesiclesFibroblast-like SynoviocytesMacrophagesRheumatoid arthritis

Substanzen

Chondroitin SulfatesCytokines

Autor:innen und Institutionen

  • School of Chemical Engineering, College of Engineering, Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea.
  • Marine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan 48513, Republic of Korea; Major of Biomedical Engineering, Division of Smart Healt…
  • Department of Biotechnology, College of Fisheries Science, Pukyong National University, Busan 48513, Republic of Korea. Electronic address: umw@pknu.ac.kr.
  • School of Chemical Engineering, College of Engineering, Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea; Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Republic…

Förderung

  • Ministry of Health and Welfare
  • Ministry of Science, ICT and Future Planning
  • National Research Foundation of Korea
  • Korea Drug Development Fund
  • Ministry of Trade, Industry and Energy

Zitieren

APA

Bui, V. D., Jeon, J., Duong, V. H., Shin, S., Lee, J., Ghahari, F., Kim, C. H., Jo, Y. J., Jung, W. K., Um, W., & Park, J. H. (2024). Chondroitin sulfate-based microneedles for transdermal delivery of stem cell-derived extracellular vesicles to treat rheumatoid arthritis. Journal of Controlled Release, 375, 105-115. https://doi.org/10.1016/j.jconrel.2024.08.050

Vancouver

Bui VD, Jeon J, Duong VH, Shin S, Lee J, Ghahari F, et al. Chondroitin sulfate-based microneedles for transdermal delivery of stem cell-derived extracellular vesicles to treat rheumatoid arthritis. Journal of Controlled Release. 2024;375:105-115. doi:10.1016/j.jconrel.2024.08.050

BibTeX
@article{Bui2024,
  author = {Bui, Van Dat and Jeon, Jueun and Duong, Van Hieu and Shin, Sol and Lee, Jungmi and Ghahari, Farrokhroo and Kim, Chan Ho and Jo, Yu Jin and Jung, Won-Kyo and Um, Wooram and Park, Jae Hyung},
  title = {Chondroitin sulfate-based microneedles for transdermal delivery of stem cell-derived extracellular vesicles to treat rheumatoid arthritis},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {375},
  pages = {105--115},
  doi = {10.1016/j.jconrel.2024.08.050}
}
Kostenlos starten →